These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30503210)

  • 1. Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.
    You L; Ma J; Wang J; Artamonova D; Wang M; Liu L; Xiang H; Severinov K; Zhang X; Wang Y
    Cell; 2019 Jan; 176(1-2):239-253.e16. PubMed ID: 30503210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
    Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
    Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
    Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
    Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupling of ssRNA cleavage with DNase activity in type III-A CRISPR-Csm revealed by cryo-EM and biochemistry.
    Guo M; Zhang K; Zhu Y; Pintilie GD; Guan X; Li S; Schmid MF; Ma Z; Chiu W; Huang Z
    Cell Res; 2019 Apr; 29(4):305-312. PubMed ID: 30814678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
    Takeshita D; Sato M; Inanaga H; Numata T
    J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus.
    Staals RH; Zhu Y; Taylor DW; Kornfeld JE; Sharma K; Barendregt A; Koehorst JJ; Vlot M; Neupane N; Varossieau K; Sakamoto K; Suzuki T; Dohmae N; Yokoyama S; Schaap PJ; Urlaub H; Heck AJ; Nogales E; Doudna JA; Shinkai A; van der Oost J
    Mol Cell; 2014 Nov; 56(4):518-30. PubMed ID: 25457165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System.
    Liu TY; Iavarone AT; Doudna JA
    PLoS One; 2017; 12(1):e0170552. PubMed ID: 28114398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cyclic oligoadenylate synthesis by the
    Nasef M; Muffly MC; Beckman AB; Rowe SJ; Walker FC; Hatoum-Aslan A; Dunkle JA
    RNA; 2019 Aug; 25(8):948-962. PubMed ID: 31076459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.
    East-Seletsky A; O'Connell MR; Knight SC; Burstein D; Cate JH; Tjian R; Doudna JA
    Nature; 2016 Oct; 538(7624):270-273. PubMed ID: 27669025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to study CRISPR RNA biogenesis and the key players involved.
    Behler J; Hess WR
    Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
    Numata T; Inanaga H; Sato C; Osawa T
    J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.
    Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y
    Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of Cpf1 in complex with CRISPR RNA.
    Dong D; Ren K; Qiu X; Zheng J; Guo M; Guan X; Liu H; Li N; Zhang B; Yang D; Ma C; Wang S; Wu D; Ma Y; Fan S; Wang J; Gao N; Huang Z
    Nature; 2016 Apr; 532(7600):522-6. PubMed ID: 27096363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas.
    Sofos N; Feng M; Stella S; Pape T; Fuglsang A; Lin J; Huang Q; Li Y; She Q; Montoya G
    Mol Cell; 2020 Sep; 79(5):741-757.e7. PubMed ID: 32730741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR RNA and anti-CRISPR protein binding to the
    Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
    J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryo-EM structure of the RNA-guided ribonuclease Cas12g.
    Li Z; Zhang H; Xiao R; Han R; Chang L
    Nat Chem Biol; 2021 Apr; 17(4):387-393. PubMed ID: 33495647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases.
    Walker FC; Chou-Zheng L; Dunkle JA; Hatoum-Aslan A
    Nucleic Acids Res; 2017 Feb; 45(4):2112-2123. PubMed ID: 28204542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
    O'Connell MR
    J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
    Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
    Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.